Antidiabetic medication use in commercially insured children and adolescents in the United States from 2004 to 2019-Reference-Cited by-同舟云学术

Antidiabetic medication use in commercially insured children and adolescents in the United States from 2004 to 2019

Published:2020-11-18 Issue:2 Volume:23 Page:444-454
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Sun Jenny W.¹²^ORCID,Hernández‐Díaz Sonia¹,Bourgeois Florence T.³,Haneuse Sebastien⁴,Brill Gregory²,Bateman Brian T.²⁵,Huybrechts Krista F.¹²

Affiliation:

1. Department of Epidemiology Harvard T. H. Chan School of Public Health Boston Massachusetts USA

2. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston Massachusetts USA

3. Department of Pediatrics Harvard Medical School Boston Massachusetts USA

4. Department of Biostatistics Harvard T. H. Chan School of Public Health Boston Massachusetts USA

5. Department of Anesthesiology, Perioperative, and Pain Medicine Brigham and Women's Hospital and Harvard Medical School Boston Massachusetts USA

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14237

Reference50 articles.

1. A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data

2. Pediatric Extrapolation in Type 2 Diabetes: Future Implications of a Workshop

3. A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity

4. U.S. Food and Drug Administration. FDA approves new treatment for pediatric patients with type 2 diabete [press release].U.S. Food and Drug Administration June 17 2019.

5. Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucagon‐like peptide‐1 receptor agonist prescribing patterns in adolescents with type 2 diabetes;Diabetes, Obesity and Metabolism;2022-05

2. Use of non‐insulin antidiabetic drugs in children and young adults – A Scandinavian drug utilization study from 2010–2019;British Journal of Clinical Pharmacology;2021-04-28